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(Kanneganti et al., 2006; Mariathasan et al., 2006; Marti-
non et al., 2006; Sutterwala et al., 2006). In addition to
these activators of innate immunity, a function for cryo-
pyrin in priming the adaptive immune system is shown.
In contrast, cryopyrin is not required for IL-1b secretion
in response to two Gram-negative bacteria (Mariathasan
et al., 2006; Sutterwala et al., 2006), MDP, or purified ag-
onists of TLR2, TLR4, TLR6, and TLR7 (Kanneganti et al.,
2006). Thus, cryopyrin participates in immune response
to specific stimuli. It is tantalizing to speculate that other
CATERPILLER proteins also demonstrate specificity.
Indeed, this is the case for Salmonella typhimurium that
requires IPAF and MDP that requires NOD2. The devel-
opment of mice deficient in additional CATERPILLER
genes will help resolve this important question.
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In this issue of Immunity, Hall et al. (2006) have exam-
ined primary macrophages from Vav12/2/Vav32/2 and
Rac12/2/Rac22/2mice to produce a new picture of Fcg
receptor and complement receptor 3 intracellular
signaling.
Many studies of phagocytic signaling mechanisms have
relied on the reductionist approach of examining indi-
vidual receptors in transfected fibroblasts or model leu-
kocyte cell lines (Underhill and Ozinsky, 2002). This pro-
cess has been extensively used to study FcgRs and
complement receptors (mainly CR3, also known as in-
tegrin Mac-1 or aMb2), which has lead to the general
view that these receptors utilize different intracellular
signaling pathways to initiate phagocytosis (Cougoule
et al., 2004). The FcgRs bind IgG-coated particles, while
CR3 recognizes particles opsonized by activated com-
plement (mainly C3bi). Engagement of FcgRs activates
a well-described intracellular signaling pathway in
phagocytes that is highly analogous to the pathways
utilized by lymphocyte antigen receptors. This pathway
involves the sequential activation of tyrosine kinases(first Src family members, then subsequently Syk),
which induces phosphorylation of a series of intracellu-
lar substrates, including Vav GEF proteins that in turn
activate Rho family GTPases (mainly Rac and Cdc42),
leading to localized actin polymerization beneath the
particle (Patel et al., 2002). Actin polymerization below
the FcgR bound particle drives membrane recruitment
and allows the phagocyte to extend filopodia around
the particle, leading to ingestion. In contrast, phago-
cytosis of complement-opsonized particles by CR3 is
tyrosine kinase independent and is thought to depend
mainly on Rho GTPase (not Rac or Cdc42) activation
(Caron and Hall, 1998). The GEFs responsible for acti-
vating Rho during CR3-mediated phagocytosis are un-
known. Although localized actin polymerization is a
feature of CR3-mediated phagocytosis, uptake via
these receptors does not involve filopodial extensions
around the particle—instead, complement-opsonized
particles tend to sink into the phagocyte (Aderem and
Underhill, 1999). These dramatic differences in intra-
cellular signaling pathways have been used as explana-
tions for why FcgR phagocytosis tends to be more
proinflammatory (i.e., result in higher oxidase activa-
tion and greater cytokine release) than CR3-mediated
phagocytosis.
Numerous studies have validated these basic obser-
vations, which were made mainly in macrophage and
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244nonhematopoietic cell lines, including some studies us-
ing primary phagocytes from genetically altered mice
(Fitzer-Attas et al., 2000). However, when thinking about
phagocytosis by different innate immune cells, it be-
comes obvious that this simple paradigm can’t be the
whole explanation. For example, it is well known that
different macrophage types respond differently to vari-
ous phagocytic signals. Similarly, it is well known that
complement receptor engagement is strongly proin-
flammatory in neutrophils and depends on a tyrosine ki-
nase-based signaling pathway (Lofgren et al., 1999;
Mocsai et al., 2002). Therefore, it is not surprising that
when Hall et al. (2006) reexamined FcgR and CR3-medi-
ated phagocytosis in primary cells from knockout mice,
they developed a very different picture of the intracellu-
lar signaling pathways used by these receptors.
Hall et al. (2006) examined FcgR and CR3-mediated
phagocytosis in bone-marrow-derived macrophages
from mice lacking all the Vav GEF proteins or from
Rac1/2 double knockout mice. In direct contrast to all
previous studies, deficiency of the Vav GEFs (i.e., cells
from vav12/2/vav22/2/vav32/2 triple mutant mice) re-
sulted in a dramatic block in CR3-mediated
Figure 1. New View of Vav GEFs and Rac1/2 Proteins in FcgR versus
CR3-Mediated Phagocytosis
Analysis of primary bone-marrow-derived macrophages suggests
that Vav1 and Vav3 are directly responsible for activation of Rac1/2
in signaling downstream of CR3 receptor engagement. The mecha-
nisms by which Vav proteins are activated in this pathway remain
unclear but may be independent of tyrosine kinases. In contrast, ty-
rosine kinases are clearly required for FcgR-mediated phagocytosis
leading to Rac1/2 activation, but the GEFs that activate these
GTPases remain to be described. Downstream of Rac1/2, the path-
ways merge, showing a common requirement for both actin poly-
merization and filopodial extension leading to particle engulfment.
How the Rho GTPase fits in is unclear, and Cdc42 is no longer in
the picture.phagocytosis without affecting FcgR-mediated particle
uptake. Single mutant vav12/2, vav22/2, or vav32/2 cells
responded normally to both phagocytic receptors, while
double mutant vav12/2/vav32/2 cells had the same phe-
notype as the triple knockout macrophages. Likewise,
the Rac1/2 doubly deficient bone marrow macrophages
were defective in both FcgR and CR3-mediated phago-
cytosis, again directly contradicting past studies. In
both these cases, the impairment of phagocytosis was
accompanied by an inability to recruit Arp2/3 to the
membrane sites below the particle, leading to severe re-
duction in actin polymerization responses. Further con-
founding observations were made when the authors
blocked Rho GTPase function bone marrow macro-
phages by incubation with cell-permeable C3 transfer-
ase inhibitor. In contrast to previous observations done
with different macrophage types, C3 transferase inhibi-
tor blocked both FcgR and CR3-mediated phagocytosis
without affecting localized actin polymerization re-
sponses below the particle. Using retroviral infection
methods, the authors reexpressed various Vav and
Rac proteins in the macrophages from the knockout
mice, demonstrating that GEF catalytic activity of Vav1
is required for its ability to restore CR3-mediated
phagocytosis to vav12/2/vav32/2 double knockout
cells, while expression of an activated Rac1 can bypass
the CR3-mediated phagocytic block in the Vav1/3 dou-
bly deficient cells. In contrast, activated Cdc42 had no
effect. As a final coup de grace, these investigators per-
formed simple transmission EM on bone marrow mac-
rophages to compare the morphology of FcgR versus
CR3-mediated phagocytosis. Again, in contrast to past
results, they found that, in these cells, actin polymeriza-
tion leading to filopodial extension around the particle is
operative in both pathways. Together, these experi-
ments produce a very different picture of intracellular
signaling by FcgRs and CR3 (Figure 1). While both
Rac1 and Rac2 are required for the actin polymerization
events needed in FcgR and CR3 phagocytosis, Vav pro-
teins serve as the Rac GEFs for only the CR3 pathway
(not the FcgR pathway), and Rho is somehow down-
stream of both phagocytic receptors. What the GEFs are
for Rac1/2 in the FcgR pathway and how the Vav1/3
proteins are regulated in the CR3 pathway (which, based
on past studies, must be via a kinase-independent path-
way) remain a mystery.
A number of explanations must underlie the dramati-
cally different view of phagocytic signaling proposed by
Hall et al. (2006). The most obvious explanation is that
these studies were done with primary bone marrow mac-
rophages, while past studies were done mainly with mac-
rophage cell lines, fibroblasts reconstituted with phago-
cytic receptors, or resting peritoneal macrophages. The
repertoire of additional Rac GEFs expressed by these
different cells may be nonoverlapping—bone marrow
macrophages must have additional GEFs, such as
DOCK2, Tiam1, or Prex1, which can activate the Rac
molecules in the FcgR pathway. Though there is a natu-
ral bias to assuming that the phagocytic signaling path-
ways defined in studies of primary cells from knockout
mice are the most likely to represent ‘‘reality,’’ in fact
one must always be aware that genetically mutant cells
have probably undergone a number of alterations in
gene expression, as a compensatory mechanism,
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245during cell development. For example, it is possible that
the Vav1/3 doubly deficient cells have upregulated
expression of other Rac GEFs in an attempt to normal-
ize Rac signaling leading to actin polymerization re-
sponses, which may mask the true involvement of Vav
proteins in FcgR signaling as suggested by cell line
types of experiments (Patel et al., 2002). Similarly, these
studies were all done with CSF-1-stimulated bone-mar-
row-derived macrophages. Obviously, this macrophage
growth factor stimulates a number of intracellular sig-
naling pathways, including tyrosine kinase pathways,
since the CSF-1R is a receptor tyrosine kinase, which
could alter the involvement of Vav proteins in FcgR ver-
sus CR3-mediated phagocytosis when compared to
non-CSF-1-treated cells. It would not be surprising if
phagocytic receptor signaling turned out to be different
in different types of leukocytes such as tissue macro-
phages or blood-derived neutrophils. As such, it may
be just as instructive to look for similarities between
newer studies done with primary cells from knockout
mice and past studies using cell line models. For exam-
ple, Hall et al. found that recruitment of activated Rac1
to the phagocytic vesicle was independent of Vav pro-
teins, as was reported in J774 macrophages (Caron
and Hall, 1998). Recruitment of Rac proteins to the
membrane for localized actin polymerization during
phagocytosis may be more dependent on the newly de-
scribed Ras GAP protein termed CAPRI and not on as-
sociation with GEFs such as the Vav family members
(Zhang et al., 2005). Overall, these exciting new results
modify the ways we think about intracellular signalingImmunity 24, March 2006 ª2006 Elsevier Inc. DOI 10.1016/j.immuni.2006.03
Cytokines, Skin, and
Smallpox–A New Link to
an Antimicrobial Peptide
Patients with atopic dermatitis (AD) have an increased
risk of infection with several viruses compared to pa-
tients with other inflammatory skin disorders such as
psoriasis. In this issue of Immunity, Howell et al.
(2006) find that the cytokine milieu in the skin of AD
patients profoundly affects the innate response to
vaccinia virus (VV) by blocking production of the anti-
microbial peptide LL-37.
Antimicrobial peptides (AMPs) are an important compo-
nent of the innate immune system in most living organ-
isms. They are of variable length, sequence, and struc-
ture, but most are small, cationic, and amphipathic. All
AMPs exhibit broad spectrum antimicrobial function
against bacteria, fungi, yeast, and enveloped viruses.
Two important subgroups of AMPs in mammals are
cathelicidins and defensins. Cathelicidins are stored in
cells in an unprocessed form, each comprised of a highlyfrom phagocyte receptors. Understanding these path-
ways, in all the different types of primary phagocytes in-
volved in innate immunity, will be critical if we are to ra-
tionally design therapeutics to target these pathways in
inflammatory and autoimmune disorders.
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conserved signal sequence, a sequence homologous
to cathelin (a cathepsin L inhibitor), and a more vari-
able C-terminal sequence with antimicrobial action. In
humans, only one cathelicidin has been identified; the
unprocessed form is termed hCAP-18 and the cleaved
antimicrobial peptide LL-37 (Zanetti, 2004). The mecha-
nism of action of most AMPs, including LL-37, is thought
to be 2-fold; first, these peptides have a net positive
charge and thus are capable of binding to microbial
membranes. AMPs also have the ability to fold into am-
phipathic structures and thus can then insert into the
membrane, thus disrupting its integrity. However, more
recently, other roles for AMPs have been proposed that
involve various interactions with host cells (discussed
further later).
hCAP-18 and LL-37 have been shown to be expressed
in neutrophils, lymphocytes, monocytes, NK cells, mast
cells, and a range of epithelial cells including keratino-
cytes and have been detected in various secretions, in-
cluding sweat (Zanetti, 2004). hCAP-18 is upregulated
in the skin in response to infection (Zanetti, 2004) and
also in inflammatory skin disorders such as psoriasis
(Ong et al., 2002). In contrast, atopic dermatitis (AD) is
a common chronic Th2-type inflammatory skin disease
